23 May 2013
Keywords: novartis, certican, gets, swiss, approval, drugs, major
Article | 30 May 2005
Swiss drugs major Novartis' Certican (everolimus) has recently been approved by Swissmedic for the prophylaxis of organ rejection in heart
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 May 2005
22 May 2013
© 2013 thepharmaletter.com